pMX-CAG-CD3-P2A-CD90.2 Citations (1)

Originally described in: An optimized retroviral toolbox for overexpression and genetic perturbation of primary lymphocytes.
van der Donk LEH, van der Spek J, van Duivenvoorde T, Ten Brink MS, Geijtenbeek TBH, Kuijl CP, van Heijst JWJ, Ates LS Biol Open. 2022 Feb 15;11(2):bio059032. doi: 10.1242/bio.059032. Epub 2022 Mar 1. PubMed Journal

---

Articles Citing pMX-CAG-CD3-P2A-CD90.2

Articles

MCB-613 exploits a collateral sensitivity in drug resistant EGFR -mutant non-small cell lung cancer through covalent inhibition of KEAP1. Bassil CF, Anderson GR, Mayro B, Askin KN, Winter PS, Gruber S, Hall TM, Hoj JP, Cerda-Smith C, Hutchinson HM, Killarney ST, Singleton KR, Qin L, Jubien-Girard K, Favreau C, Martin AR, Robert G, Benhida R, Auberger P, Pendergast AM, Lonard DM, Puissant A, Wood KC. bioRxiv. 2023 Jan 19:2023.01.17.524094. doi: 10.1101/2023.01.17.524094. Preprint. PubMed

If you have published an article using this material, please email us at to have your article added to this page.